There are 449 resources available
Navigating the current treatment landscape for common EGFR-mutant NSCLC
Presenter: Raffaele Califano, Jordi Remon Masip
Session: Janssen Pharmaceutica NV - Guiding clinical decision-making in advanced EGFR-mutant NSCLC
Resources:
Webcast
Advances in EGFR exon20ins mutations in NSCLC
Presenter: Pascale Tomasini
Session: Janssen Pharmaceutica NV - Guiding clinical decision-making in advanced EGFR-mutant NSCLC
Resources:
Webcast
Living with lung cancer: Implementing shared-decision making with our patients
Presenter: Martin Reck
Session: Janssen Pharmaceutica NV - Guiding clinical decision-making in advanced EGFR-mutant NSCLC
Resources:
Webcast
Tumor biology and molecular subtypes of SCLC
Presenter: carl gay
Session: Small cells: Still a big issue
Resources:
Slides
Webcast
Case presentation
Presenter: Hongcheng Zhu
Session: Approaches in N2
Resources:
Slides
Webcast
New and promising chekpoints to block
Presenter: Martin Reck
Session: IO therapies: Beyond checkpoint inhibitors
Resources:
Slides
Webcast
New developments in radiation treatment in SCLC
Presenter: Jose Belderbos
Session: Small cells: Still a big issue
Resources:
Slides
Webcast
PACIFIC is the best approach for N2 disease
Presenter: Clara Chan
Session: Approaches in N2
Resources:
Slides
Webcast
Bi-specific Abs in development
Presenter: Daniel Shao Weng Tan
Session: IO therapies: Beyond checkpoint inhibitors
Resources:
Slides
Webcast
Recent advances and challenges: IO in SCLC
Presenter: JUNKO TANIZAKI
Session: Small cells: Still a big issue
Resources:
Slides
Webcast